Patch pump vs. shots: can a smart insulin device tame Steroid-Related blood sugar spikes?

NCT ID NCT07652528

First seen Jun 26, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This study looks at whether a wearable insulin patch pump, guided by a continuous glucose monitor, can better control high blood sugar caused by high-dose steroids in people with sudden hearing loss and diabetes or prediabetes. About 44 participants will be randomly assigned to either the patch pump or standard insulin injections. The goal is to see which method keeps blood sugar in a safer range during the 9-day steroid treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Insulin patch pump (CareLevo) and insulin glargine (Lantus) injections
What this could lead to
If successful, this could show that a patch pump is a better way to manage temporary high blood sugar caused by steroids in people with hearing loss and diabetes.
What could go wrong
This is a small, early-stage trial with only 44 participants, so results may not apply to everyone. The pump is new and may have technical issues or not work better than standard injections.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREDIABETES / TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.